The Medical Letter on Drugs and Therapeutics
				
			FROM
ISSUE 1727
    
   			ISSUE 1727
April 28, 2025
                			
                		 Issue 1727
                		- Drugs for Open-Angle Glaucoma
 - A Fixed-Dose Combination of Meloxicam and Rizatriptan (Symbravo) for Migraine
 - In Brief: Epinephrine 1 mg Nasal Spray (neffy)
 - In Brief: A New Indication for Tenecteplase (TNKase)
 - Diazoxide Choline (Vykat XR) for Prader-Willi Syndrome-Associated Hyperphagia (online only)
 - Revakinagene Taroretcel (Encelto) – A Gene Therapy for Idiopathic Macular Telangiectasia (online only)
 
					Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
				
				Drugs for Open-Angle Glaucoma
April 28, 2025 (Issue: 1727)
				Glaucoma is a progressive optic neuropathy
associated with increased intraocular pressure
(IOP; normal range 8-22 mm Hg), which is the only
disease-related factor that can be modified. Topical
drugs that lower IOP are the first line of treatment...more
        			
        			
					
					
				
        			
				The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
				